Candesant Biomedical Receives FDA Clearance of Brella™

/PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive...

Related Keywords

New Orleans , Louisiana , United States , Canada , American , Americans , Canadian , Suzanne Haber , Dee Anna Glaser , Candesant Biomedical Inc , Consumer Survey On Cosmetic Dermatologic Procedures , International Hyperhidrosis Society , Candesant Brella Early Experience Program , A National , Brella Early Experience Program , Office Treatment , Patch Technology , Sweat Solutions , Drug Administration , Canadian Hyperhidrosis Advisory Committee , American Society For Dermatologic Surgery , American Academy Of Dermatology , Significantly Improves Quality , Including Reducing , Negative Impact , Daily Activities , Single In Office , Multicenter Pivotal , Demonstrating Brella , Treated Participants Maintained Sweat Reduction , Three Months , Candesant Biomedical , Minute Sweatcontrol Patch , Multichannel News Release , Niquette Hunt , Brella Sweatcontrol , Brella Sweatcontrol Patch , International Hyperhidrosis , Brella Early Experience , Excessive Sweating , American Society , Dermatologic Surgery , Hyperhidrosis Disease Severity Scale , American Academy , Control Patch , Trade Name , Patient Experience With Hyperhidrosis , National Survey , Pilot Study , Novel Device , Subjects With Axillary , Arch Dermatol Res , Under Age , Cosmetic Dermatologic , Press Release , Accessed Feb , Excessive Axillary Sweating , Primary Axillary , Canadian Hyperhidrosis Advisory ,